Download presentation
Presentation is loading. Please wait.
Published byMarian Daniels Modified over 9 years ago
1
FEVER DENGUE VIRUS: NO ONE IS SAFE Prepared by: Mohamed Abdul Gader
2
Alternative Names West Nile Fever Break Bone Fever Dengue like Disease Onyong- Nyang Fever
3
WHAT IS DENGUE ? Dengue is an arthropod-borne disease caused by any one of four closely related viruses. Infection with one serotype of dengue virus provides immunity to that serotype for life. A person can be infected as many as four times, once with each serotype. Holly R. Hughes 2009
4
DENGUE (cont’d) Dengue virus (DEN) is a member of the Flavivirus genus in the Flaviviridae family of single-stranded, positive-polarity, enveloped RNA viruses. Dengue viruses are transmitted from person to person by Aedes mosquitoes (most often Aedes aegypti) in the domestic environment. Burke, D. S., and T. P. Monath. 2001.
5
Dengue Virus Electron Micrograms
6
About 50–100 million cases of dengue fever and 500,000 cases of Dengue Hemorrhagic Fever (DHF), resulting in around 24,000 deaths, are reported annually. dengue is often found in urban areas of tropical nations, including Puerto Rico, Singapore, Malaysia, Taiwan, Thailand, Indonesia, Philippines, Pakistan, India, Brazil, Vietnam, Guyana, Venezuela, Bangladesh. www.plosone.org 2008
7
Dengue’s vectors are two types of Aedes mosquitoes; Aedes aegypti and Aedes albopictus. However, it is the Aedes aegypti species that is most notorious for transmitting dengue. http://www.cdc.gov
8
1.Mosquitoes transmit dengue to human dendritic cells 2. Dengue targets areas with high WBC counts (liver, spleen, lymph nodes, bone marrow, and glands) 3. Dengue enters WBCs & lymphatic tissue 4. Dengue enters blood circulation 3 4 1 2 3 HOW DENGUE SPREADS
9
Transmission of Dengue Virus by Aedes aegypti http://www.cdc.gov
10
DENGUE (cont’d) Three Manifestations: 1. Dengue Fever 2. Dengue Hemorrhagic Fever 3. Dengue Shock Syndrome Leads to death in 5% of cases More dangerous if infected second time by different serotype
11
Dengue Fever Dengue Fever is an acute febrile illness of 2-7 days duration (sometimes with two peaks) with two or more of the following manifestations: Headache retro -orbital pain myalgia/arthralgia rash haemorrhagic manifestation (petechiae and positive tourniquet test). leukopenia
12
Dengue Hemorrhagic Fever (DHF) A severe form of Dengue resulting from a second infection of a different serotype of the virus First serotype … Dengue fever … Recovery Second serotype … Risk of DHF
13
http://www.cdc.gov/ncidod/dvbid/dengue/slideset/set1/images/petechiae2-small.jpg P E T E C H I A E
14
P U R P U R A http://www.pediatrics.wisc.edu/education/derm/tutb/85m.jpg
15
http://www-medlib.med.utah.edu/WebPath/ATHHTML/ATH036.html E C C H Y M O S I S
16
http://www.cgste.mq/brainstorm/dengue/image/hemo.gif NASAL HEMORRHAGING
17
Dengue Shock Syndrome Dengue Shock Syndrome (DSS) All the above criteria of DHF plus signs of circulatory failure manifested by rapid and weak pulse, narrow pulse pressure, hypotension for age, cold and clammy skin and restlessness
18
IMMUNE RESPONSE Stephenson, 2005
19
FIRST INFECTION Humoral and cellular immune response - Ab serum neutralizing levels increase - T-lymphocytes activated by dendritic cells - Memory cells develop antibodies to fight off future infection of same serotype Stephenson, 2005
20
SECOND INFECTION Antibody dependent enhancement - Enhancing immunoglobulin G (IgG) antibodies - Fc Receptors Stephenson, 2005
21
IMMUNO PATHOGENECITY Dengue viruses replicate within the cytoplasm of infected cells after receptor-mediated entry The known sites of viral replication in vivo are leukocytes, especially circulating B cells, Kupffer cells, and tissue macrophages outside of the neuroaxis Infection of dendritic cells by dengue viruses may play an important role in disease pathogenesis Magill, 2005
22
Continue ….. Infection with one dengue virus type appears to confer lifelong homologous immunity but little to no heterologous immunity Complement is activated, generating vasoactive cleavage products C3a and C5a. Immune activation and the resulting cytokine and complement cascade appear to account for the plasma leakage and hemostatic defects that occur in DHF Magill, 2005
23
Hypothesis on Pathogenesis of DHF -DSS Persons who have experienced a dengue infection develop serum antibodies that can neutralize the dengue virus of that same (homologous) serotype
24
Homologous Antibodies Form Non-Infectious Complexes
25
In a subsequent infection, the pre-existing heterologous antibodies form complexes with the new infecting virus serotype, but do not neutralize the new virus. Hypothesis on Pathogenesis of DHF-DSS
26
Heterologous Antibodies Form Infectious Complexes
27
Antibody-dependent enhancement is the process in which certain strains of dengue virus, complexed with non- neutralizing antibodies, can enter a greater proportion of cells of the mononuclear lineage, thus increasing virus production. Hypothesis on Pathogenesis of DHF-DSS
28
Heterologous Complexes Enter More Monocytes, Where Virus Replicates
29
Infected monocytes release vasoactive mediators, resulting in increased vascular permeability and hemorrhagic manifestations that characterize DHF and DSS. Hypothesis on Pathogenesis of DHF-DSS
30
Immunopathogenic Cascade of DHF/DSS Macrophage – monocyte infection Previous infection with heterologous Dengue serotype results in production of non protective antiviral antibodies These Ab bind to the virion’s surface Fc receptor and focus the Dengue virus on to the target cells – macro/monocytes T cell - cytokines, interferon, TNF alpha
31
(Libraty, D.H., et al. 2004) Elevations of circulating levels of activation markers including soluble TNF receptors, soluble IL-2 receptors, and soluble CD8 have been shown to correlate with disease severity. http://www.jci.org 2004
32
(Jamuna vadivelue 2007) Cytotoxic T lymphocytes (CTL) play an important role in the elimination of dengue virus-infected cells. Identification of antigenic peptides recognized by dengue virus-specific CTL may suggest new ways to suppress viral replication and prevent persistent infection Jamuna vadivelue 2007
33
( Chen ST, Lin YL 2008) Dr. Yi-Ling Lin in the Institute of Biomedical Sciences found that dengue virus binds to a human macrophage surface lectin receptor called CLEC5A and stimulates proinflammatory cytokines release. Lin YL 2008
34
Diagnosis Isolation of dengue virus Increased IgM or IgG antibody titer Dengue antigen detection by immunohistochemistry, immunofluroscence, ELISA PCR leucopenia,thrompocytopenia
35
Treatment of DF No antiviral agents are of proven value Supportive measures - Vector barrier Avoid Aspirin and Steroids should not be used Fluid replacement to avoid hemoconc. Children below 12 require careful watch for DHF / DSS
36
DHF / DSS Intensive Care Oxygen Rehydration Barrier Nursing Mosquito Screen Blood or platelet Transfusions
37
Thank You for Your Attention
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.